================================================================================
INNOVATION GAP ANALYSIS REPORT
Cross-Domain Topic Projection: Scientific Papers vs. Patents
================================================================================

SUMMARY STATISTICS:
--------------------------------------------------------------------------------
Scientific Papers Analyzed: 223
Patents Analyzed: 24265
Topics Identified: 6
Average Gap Index: 0.13

GHOST TOPICS (High Academic Activity, Low Commercial Activity):
================================================================================

1_the_of_and_in
--------------------------------------------------------------------------------
  Gap Index: 0.88
  Scientific Papers: 43 (19.3%)
  Patents: 560 (2.3%)
  Likely Barrier: TECHNICAL INFEASIBILITY
  Key Terms: the, of, and, in, to

4_the_of_and_biodiesel
--------------------------------------------------------------------------------
  Gap Index: 0.81
  Scientific Papers: 27 (12.1%)
  Patents: 553 (2.3%)
  Likely Barrier: TECHNICAL INFEASIBILITY
  Key Terms: the, of, and, biodiesel, in

0_the_of_and_in
--------------------------------------------------------------------------------
  Gap Index: 0.81
  Scientific Papers: 67 (30.0%)
  Patents: 1415 (5.8%)
  Likely Barrier: TECHNICAL INFEASIBILITY
  Key Terms: the, of, and, in, to

5_of_and_the_in
--------------------------------------------------------------------------------
  Gap Index: 0.61
  Scientific Papers: 21 (9.4%)
  Patents: 895 (3.7%)
  Likely Barrier: SCALING CHALLENGE
  Key Terms: of, and, the, in, to


BALANCED TOPICS (Healthy Science-Technology Translation):
================================================================================

⚠️  NO BALANCED TOPICS FOUND
This suggests systematic commercialization failure across all areas.


KEY FINDINGS:
================================================================================

1. Overall Innovation Gap: 0.13
   - 3 topics with CRITICAL gaps (>0.7)
   - 4 topics with HIGH gaps (>0.5)

2. Barrier Classification:
   - TECHNICAL INFEASIBILITY: 3 topics
   - OVER-PATENTED (Patent Thicket): 2 topics
   - SCALING CHALLENGE: 1 topics

3. Implications for Commercialization:

================================================================================
END OF REPORT
================================================================================
